ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicine

• Published in: Molecular biology reports Vol. 48; no. 2; pp. 1883 - 1901
• Main Authors: Juan-Carlos, Pérez-De Marcos, Perla-Lidia, Pérez-Pineda, Stephanie-Talia, Méndez-Morales, Mónica-Griselda, Arellano-Mendoza, Luz-María, Torres-Espíndola
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01.02.2021; Springer Nature B.V
• Subjects: ABC transporter; Animal Anatomy; Animal Biochemistry; Antineoplastic drugs; Biomedical and Life Sciences; Cancer; Cancer therapies; Chemoresistance; Chemotherapy; Drug therapy; Genetic variability; Histology; Homeostasis; Life Sciences; Morphology; Multidrug resistance; Multidrug resistant organisms; Precision medicine; Protein transport; Review; Toxicity; ABC transporters; Molecular biology; Personalized medicine; Multidrug resistance; Pharmacogenomics; Cancer
• ISSN: 0301-4851; 1573-4978
• DOI: 10.1007/s11033-021-06155-w

The ATP binding-cassette superfamily corresponds the mostly transmembrane transporters family found in humans. These proteins actively transport endogenous and exogenous substrates through biological membranes in body tissues, so they have an important role in the regulation of many physiological functions necessary for human homeostasis, as well as in response regulation to several pharmacological substrates. The development of multidrug resistance has become one of the main troubles in conventional chemotherapy in different illnesses including cancer, being the increased efflux of antineoplastic drugs the main reason for this multidrug resistance, with a key role of the ABC superfamily. Likely, the interindividual variability in the pharmacological response among patients is well known, and may be due to intrinsically factors of the disease, genetic and environmental ones. Thus, the understanding of this variability, especially the genetic variability associated with the efficacy and toxicity of drugs, can provide a safer and more effective pharmacological treatment, so ABC genes are considered as important regulators due to their relationship with the reduction in pharmacological response. In this review, updated information about transporters belonging to this superfamily was collected, the possible role of these transporters in cancer, the role of genetic variability in their genes, as well as some therapeutic tools that have been tried to raise against main transporters associated with chemoresistance in cancer.